迈克生物：关于限制性股票回购注销完成的公告

Core Points - The company announced the repurchase and cancellation of restricted stocks involving 30 incentive targets, totaling 3,844,966 shares, which accounts for approximately 0.63% of the company's total share capital before the repurchase [1] - The company has received notification from China Securities Depository and Clearing Corporation Limited Shenzhen Branch confirming the completion of the repurchase and cancellation of restricted stocks [1] - Following the completion of the repurchase, the company's total share capital has changed from 612,469,590 shares to 608,624,624 shares [1]